Abstract: The present disclosure discloses a preparation method for a silicon/carbon composite anode material and use of thereof. The preparation method includes the following steps: heating a hypercrosslinked polymer in an inert atmosphere for carbonization to obtain a porous carbide; mixing the porous carbide with a silicon-containing solution to obtain a silicon-containing porous carbide suspension; and adding a complexing agent, a metal salt, and a reducing agent to the silicon-containing porous carbide suspension to allow a reaction, and after the reaction is completed, conducting solid-liquid separation to obtain a solid, and heating the solid in an inert atmosphere to obtain the silicon/carbon composite anode material. In the present disclosure, the metal salt is reduced with the reducing agent under an action of the complexing agent through a metal-embedded-into-silicon treatment, such that a metal layer is formed on a silicon layer adsorbed on the porous carbide.

Abstract: Disclosed in the present invention is a method for surface modification of a lithium transition metal oxide positive electrode material, including: adding a first additive, a second additive, and a lithium transition metal oxide to water to obtain a first slurry, the first additive being a lithium-containing phosphate, and the second additive being an acidic solution of a Y3+ or Al3+ salt; dropwise adding a third additive to the firs slurry to obtain a second slurry, the third additive being an acidic solution of a TiO2+ or ZrO2+ salt; dropwise adding a fourth additive to the second slurry to obtain a third slurry, the fourth additive being an acidic solution of a AlO2? salt; and performing centrifugation and drying on the third slurry to obtain an intermediate product, mixing the intermediate product with a large-particle positive electrode material, and performing sintering to obtain a surface-modified lithium transition metal oxide material.

Abstract: The present disclosure discloses a method for preparing a porous microsphere carbon negative electrode material and an application thereof, the method comprising steps of: mixing plant fiber with a halogenated lithium salt to obtain a mixed solid, heating the mixed solid and introducing an oxidizing gas to obtain a pre-dissociated product; mixing the pre-dissociated product with a dissociation solution and heating for reaction to obtain a dissociated cellulose solution; and adding a hybrid to the dissociated cellulose solution to obtain a hybrid solution, spray-drying the hybrid solution to obtain a microsphere precursor, and heating the microsphere precursor in an inert atmosphere to obtain the porous microsphere carbon negative electrode material.

Abstract: The present disclosure discloses a prelithiation reagent for a lithium-ion battery (LIB), and a preparation method therefor and use thereof. The prelithiation reagent for the LIB has a chemical formula of Li5FeO4@C; and the prelithiation reagent for the LIB has a structure of secondary particles generated from the agglomeration of Li5FeO4 primary particles, and carbon is coated on a surface of the Li5FeO4 primary particles. In the present disclosure, a carbon source is mixed with a soluble salt of Fe, such that Fe ions are attached to the carbon source; then aqueous ammonia is added, such that a hydroxide with small particles and high dispersibility is generated; and then a solvothermal reaction is conducted to obtain a nano-scale oxide.

Abstract: The present disclosure discloses a method for preparing a ternary cathode precursor material with low sulfur content and high specific surface area, and belongs to the field of lithium ion battery materials. In the present disclosure, by using a continuous filter with a spraying device for concentrating a reaction material, sulfur impurities can be uniformly removed in a reaction stage, and neither are the reaction environment and the production efficiency affected, nor does introduction of new impurities occur. In addition, by removing the mother liquor by means of negative pressure suction filtration, the material can be oxidized uniformly in a controlled manner, and the specific surface area of the ternary cathode precursor material is uniformly increased, so that during sintering, lithium ions more easily enter the interior of particles of the ternary cathode precursor material, thus exerting a higher capacity.

Abstract: A method for enriching lithium from a lithium clay includes the following steps (1) the raw ore were crushed to produce fine particles, (2) performing rougher on the fine particles by adding ferric sulfate or ferric nitrate, sodium oleate, and cocoamine to obtain rough concentrate and rough tailing, (3) finely separating the rough concentrate to obtain the first part of concentrate, (4) re-grinding the rough tailing by ball mill, (5) performing rougher on the reground tailing to obtain reground rough concentrate and re-ground rough tailing, (6) performing cleaner on the reground rough concentrate to obtain the second part of concentrate, and (7) performing scavenger on the reground rough tailing to obtain the cleaned tailing.

Abstract: Disclosed are a manganese-doped cobaltosic tetroxide, and a preparation method and application thereof, belonging to the field of battery materials. The preparation method of the manganese-doped cobaltosic tetroxide of the disclosure dopes a manganese element into cobalt carbonate with a specific process and matched with a composite surfactant, which can obtain manganese-doped cobaltosic tetroxide particle products with uniform particle size, dispersion and fineness through high-temperature sintering, a proportion of low-valence manganese in the doped manganese is high, and a crystal form of the products obtained by sintering is complete. The preparation method is simple in operation and can realize industrial large-scale production. The manganese-doped cobaltosic tetroxide prepared by the preparation method and the application thereof are also disclosed.

Abstract: Provided is a treatment method of waste water containing ferricyanide complex and oxalate, comprising under the condition of weak acidity to weak alkalinity, firstly adding an appropriate amount of divalent manganese ions to make the divalent manganese ions combined with ferrocyanide ions and part of oxalate ions in wastewater to form a mixed slag mainly composed of manganese ferrocyanide to achieve the purpose of removing most of the cyanide and a small amount of organic substance; adding excess divalent manganese ions to the first filtrate to make the divalent manganese ions fully combined with the oxalate in the wastewater to achieve the purpose of removing organic substance, and then adding an appropriate amount of alkali to the second filtrate to form precipitation to achieve the purpose of recovering manganese; then adding an appropriate amount of ferrous salt to achieve the purpose of removing the remaining cyanide and organic substance.

Abstract: A method for regulating a particle size of Prussian white, includes (1) adding a food-grade manganese sulfate solution and a complexing agent solution into a sodium ferrocyanide solution for a precipitation reaction to generate Prussian white crystal nucleus; (2) replacing the food-grade manganese sulfate solution with an industrial-grade manganese sulfate solution, and keeping other conditions unchanged, so that the Prussian white crystal nucleus grow continuously to obtain a slurry; and (3) successively subjecting the slurry to an aging reaction, solid-liquid separation, washing and drying to obtain a Prussian white product with a specific particle size. The food-grade manganese sulfate solution, and the sodium ferrocyanide solution are subjected to the precipitation reaction, and then the industrial-grade manganese sulfate solution are added to continue a precipitation reaction.

Abstract: The subject invention pertains to compositions and methods for treating neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), multiple sclerosis, epilepsy, stroke, alcohol withdrawal, progressive supranuclear palsy (PSP), Pick's disease (PiD), corticobasal degeneration (CBD), frontotemporal dementia or parkinsonism linked to chromosome 17 (FTDP-17). The methods of the subject invention further relate to methods of fermentation of bacterial cells and methods of tautomerization of the subject compounds.

Abstract: The subject invention pertains to compositions comprising albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo. The subject invention further pertains to methods of treating a subject with HIV using albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo.

Abstract: The subject invention pertains to compositions comprising albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo. The subject invention further pertains to methods of treating a subject with HIV using albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo.

Abstract: The subject invention pertains to compositions and methods for treating neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), multiple sclerosis, epilepsy, stroke, alcohol withdrawal, progressive supranuclear palsy (PSP), Pick's disease (PiD), corticobasal degeneration (CBD), frontotemporal dementia or parkinsonism linked to chromosome 17 (FTDP-17). The methods of the subject invention further relate to methods of fermentation of bacterial cells and methods of tautomerization of the subject compounds.

Abstract: Compositions of angiostatic agents for treating choroidal neovascularization resulting from ocular surgery or from trauma to ocular tissue and methods for their use are disclosed.

Abstract: Compositions of angiostatic agents for treating choroidal neovascularization resulting from ocular surgery or from trauma to ocular tissue and methods for their use are disclosed.